Chemo Insensitive Sarcomas
Showing 1 - 25 of 1,320
HNSCC, Head Neck Cancer, Oropharynx Cancer Trial in Groningen (blood draws)
Recruiting
- HNSCC
- +4 more
- blood draws
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 23, 2023
Thoracic Sarcomas, Thorasic Cancers, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura Trial run by the NCI
Terminated
- Thoracic Sarcomas
- +4 more
- H1299 cell lysates
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 27, 2021
Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)
Active, not recruiting
- Sarcoma, Soft Tissue
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Oct 29, 2023
Cancer Patients: Non-invasive Optical Measurements of the Brain
Withdrawn
- Signs and Symptoms
- Diffuse optical spectroscopy and Near infrared spectroscopy
- (no location specified)
Oct 28, 2022
Glioblastoma, Surgery, High Grade Glioma Trial in Danville, Wilkes-Barre (radiation, drug, procedure)
Recruiting
- Glioblastoma
- +2 more
- Neoadjuvant chemoradiation
- +2 more
-
Danville, Pennsylvania
- +1 more
Jan 24, 2022
Protocol For Bone and Soft Tissue Sarcomas
Completed
- Sarcomas
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
Apr 11, 2023
SCCHN, Squamous Cell Carcinoma Trial in Birmingham (Cisplatin)
Recruiting
- SCCHN
- Squamous Cell Carcinoma
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 5, 2023
Endometrial Tumors, Atypical Endometrial Hyperplasia, Progesterone Resistance Trial in Shanghai (GnRHa, Letrozole 2.5mg,
Recruiting
- Endometrial Neoplasms
- +2 more
- GnRHa
- +3 more
-
Shanghai, Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Jul 29, 2022
Effectiveness, Sexuality Trial in Zhengzhou (Lenvatinib mesylate capsule)
Not yet recruiting
- Effectiveness
- Sexuality
- Lenvatinib mesylate capsule
-
Zhengzhou, Henan, ChinaDepartment of Bone and Soft Tissue ,Henan Cancer Hospital
Jan 31, 2023
Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in
Active, not recruiting
- Metastatic Melanoma
- +22 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 19, 2023
Hyperspectral Imaging Technique in the Treatment of IMN by TAC
Not yet recruiting
- Idiopathic Membranous Nephropathy
- +2 more
- Tacrolimus for the treatment of IMN
- (no location specified)
Mar 31, 2023
Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)
Not yet recruiting
- Rectal Cancer
- Chemoradiation treatment
- 18FDG-PET/MRI scan
- (no location specified)
Sep 26, 2023
Hyperspectral Imaging Technique in CTX Treatment of IMN
Not yet recruiting
- Hyperspectral Imaging
- +2 more
- Microscopic hyperspectral imaging system
- (no location specified)
Apr 29, 2023
Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)
Recruiting
- Soft Tissue Sarcoma
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 7, 2022
An Imaging Agent With Positron Emission Tomography/Magnetic
Recruiting
- Recurrent Soft Tissue Sarcoma
- +2 more
- Fluorodopa F 18
- +4 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 4, 2023
Soft Tissue Sarcoma Trial in Shanghai (Fruquintinib)
Recruiting
- Soft Tissue Sarcoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 1, 2022
Neoadjuvant, Immunotherapy, Sarcoma,Soft Tissue Trial in Warsaw (Pembrolizumab, Eftilagimod alpha)
Recruiting
- Neoadjuvant
- +3 more
- Pembrolizumab, Eftilagimod alpha
-
Warsaw, PolandMaria Sklodowska-Curie National Research Institute of Oncology
Nov 7, 2023
Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)
Not yet recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Cyclophosphamide
- attIL2-T cells
-
Houston, TexasM D Anderson Cancer Center
Nov 10, 2022
Status of Surgical Resection and Histologic Subtype as
Completed
- Liposarcoma of Soft Tissue
- Surgical Procedure, Unspecified
- Retroperitoneal Liposarcoma resection
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da Universidade d
Jun 18, 2022
Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)
Active, not recruiting
- Refractory Soft Tissue Sarcomas
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022
Study of Exosomes in Monitoring Patients With Sarcoma (EXOSARC)
Recruiting
- Sarcoma
- Blood samples
-
Besançon, France
- +2 more
Mar 24, 2022